Launch of a Spineway share consolidation
The Extraordinary General Meeting of Spineway's shareholders was held on Monday, July 25, 2022 at 5:00 p.m. at the Company's headquarters. The...
The Extraordinary General Meeting of Spineway's shareholders was held on Monday, July 25, 2022 at 5:00 p.m. at the Company's headquarters. The...
Read more
Spine Innovations, a spin-off from Groupe FH Ortho’s spine activity and majority owned by the investment fund LBO France, has over 25 years of expertise...
Read more
Committed to a growth trajectory, Spineway saw its sales accelerate over the 2nd quarter 2022 to total turnover of 1,8 M€, an increase of 74% compared...
Read more
This congress was the opportunity to present several new products for the first time and, in particular theranges resulting from the acquisition of the...
Read more
In line with the last quarter of 2021, Spineway confirms its growth momentum and totals revenues of €1.3 million for the first quarter of 2022, up 55%...
Read more
The Annual and Extraordinary General Meeting of Spineway held on Friday, 23 March 2022 at 4:00 p.m. at at the Group's headquarters was unable to be...
Read more
Spineway informs its shareholders that they are convened to a Combined General Meeting on Friday, March 23, 2022 at 4:00 p.m. at the Group's...
Read more
Spineway confirms sound orientation of its 2021 fiscal year with a turnover of €4.3 million1 up 27% compared to 2020, despite the still penalizing pandemic...
Read more
This growth was driven in particular by high sales performances in the Group's historical areas. Thus, Latin America recorded revenues of nearly €2 million,...
Read more
The information provided on the following pages is exclusively intended for healthcare professionals. By clicking here you certify being a healthcare professional.